No. of assessed patients | Cycle 1 | Cycle 2 | Cycle 3 |
|
37 | 30 | 29 | ||
Events | Number (%) | Number (%) | Number (%) | P-value |
Any Grade III & IV toxicity | 17 (49.5%) | 6 (20%) | 4 (13.8%) | 0.007 |
Diarrhea | 8 (21.6%) | 4 (13.3%) | 2 (6.9%) | 0.236 |
Mucositis | 9 (24.3%) | 3 (10%) | 1 (3.4%) | 0.038 |
Myelosuppression | 12 (32.4%) | 2 (6.7%) | 3 (10.3%) | 0.01 |
Neuropathy | 2 (5.4%) | 1 (3.3%) | 1 (3.4%) | 0.89 |
Nausea & Vomiting | 2 (5.4%) | 2 (6.7%) | 0 (0.0%) | 0.392 |
Treatment related mortality* | 7 (18.9%) | 1 (3.3%) | 0 (0.0%) | 0.01 |